Sunday, December 8, 2013
U.S. health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences Inc. that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.
The latest hopes of curing AIDS were dashed Friday when U.S. researchers said HIV returned in two men who briefly eradicated the virus after bone marrow transplants for cancer.
A faulty connection between where the brain stores the auditory building blocks of language and where it processes them may be to blame for dyslexia, a new study suggests.
Saturday, December 7, 2013
Researchers cast doubt on the prevailing wisdom that vitamin D supplements can prevent conditions like cancer, diabetes and heart disease, saying on Friday low vitamin D may be a consequence, not a cause, of ill health.
Friday, December 6, 2013
The number of people suffering from dementia worldwide is set to explode in the coming decades as the population ages, tripling by 2050, according to a study released Thursday.
The first full-face transplant patients in the U.S. are growing into their new appearances — literally.
Thursday, December 5, 2013
The Taiwan branch of the multinational pharmaceutical firm GlaxoSmithKline (GSK) yesterday donated
Wednesday, December 4, 2013
Health authorities in the capital of the United Arab Emirates say a woman has died from a SARS-like virus that has been centered in neighboring Saudi Arabia.
Tuesday, December 3, 2013
A class action over birth defects linked to the morning sickness drug thalidomide was settled in an Australian court Monday, with the British distributor agreeing to pay victims AU$89 million (US$81 million).